PCOS vs PCOD: What's the Difference? (Canadian Guide)
In the PCOD vs. PCOS comparison, PCOD is an older, regional term while PCOS, now renamed PMOS, is the diagnosis Canadian clinicians actually chart. PCOD (polycystic ovarian disease) emphasizes the ovarian-appearance finding on ultrasound and remains common in South Asian medical practice and patient education. That's why many Canadians of South Asian background encounter it long before they see a Canadian physician. PCOS (polycystic ovary syndrome) is the internationally recognized syndrome, diagnosed against the Rotterdam criteria (two of three features: androgen excess, ovulatory dysfunction, polycystic ovarian morphology) and endorsed by the Society of Obstetricians and Gynaecologists of Canada. In May 2026, PCOS itself was renamed PMOS (more on that below); the diagnostic standard did not change. If your prior records from elsewhere say PCOD, a Canadian workup doesn't start from zero. See what is PCOS for how diagnosis and testing actually work here. Quebec and francophone communities use a third term, SOPK, which maps directly onto PCOS/PMOS rather than PCOD. None of this describes two different diseases competing for the same patient. It's one condition, named with different precision depending on where and when the term was coined.
Naming note: In May 2026, PCOS was formally renamed polyendocrine metabolic ovarian syndrome (PMOS) by global consensus published in The Lancet. Everything in this comparison applies to PMOS just as it applies to PCOS. See our PCOS-to-PMOS explainer for the rename context. This article keeps using "PCOS" alongside PCOD because those remain the terms patients are actively comparing during the transition period.
Why this comparison matters for Canadians
If you've spent any time in Canadian waiting rooms, family group chats, or health forums, you've probably run into both PCOD and PCOS used to describe the same cluster of symptoms: irregular periods, acne, unwanted hair growth, weight that doesn't respond the way it should. That overlap isn't random. Canada has one of the largest South Asian populations outside South Asia itself, concentrated heavily in the Greater Toronto Area, Metro Vancouver, and Calgary. PCOD is the term most widely used across South Asian healthcare systems and patient education, and a lot of Canadians grew up hearing it from family, from doctors abroad, or from content aimed at Indian, Pakistani, or Bangladeshi audiences long before they ever sat in a Canadian exam room.
Then they hit PCOS, or its 2026 rename PMOS, once they're inside the Canadian system, and the two labels don't obviously map onto each other. That's exactly why this comparison earns its own page rather than a paragraph inside a bigger article: getting the terms straight isn't pedantic. It changes how you read your own old paperwork, what a Canadian workup should actually involve, and whether a prior diagnosis from somewhere else "still counts." For every other PCOS resource we publish, start at our PCOS resource hub.
Take the free 3-minute quiz
PCOD vs PCOS: what's actually different
Start with the plain definitions, because the acronyms alone don't tell you much.
PCOD (polycystic ovarian disease) is the older term. It centres on a single finding: an ultrasound picture showing multiple small, immature follicles on the ovaries. In practice, PCOD has been used loosely, sometimes for the ultrasound finding alone, sometimes as informal shorthand for a milder symptom picture that skips the fuller hormonal and metabolic disturbance. It has never had a single, internationally standardized diagnostic threshold the way PCOS does.
PCOS (polycystic ovary syndrome) is the current clinical term, used by the Society of Obstetricians and Gynaecologists of Canada, the Endocrine Society, and international guidelines. "Syndrome" is doing real work in that name: PCOS describes a cluster of features acting together (androgen excess, ovulatory dysfunction, and often, though not always, the ovarian-morphology finding PCOD focuses on), diagnosed against a specific, internationally agreed standard: the Rotterdam criteria.
The practical difference comes down to scope. PCOD points at one piece of the picture. PCOS names the whole syndrome, including the insulin resistance and androgen excess that drive most of the long-term health risk. That scope gap is also why, in May 2026, PCOS itself was renamed polyendocrine metabolic ovarian syndrome, or PMOS. The new name puts the metabolic and multi-hormone features into the label itself, something neither PCOD nor the old PCOS name did.
The difference between PCOS and PCOD, at a glance
Put side by side, the practical differences look like this:
| PCOD | PCOS / PMOS |
|---|
| Full term | Polycystic ovarian disease | Polycystic ovary syndrome (renamed polyendocrine metabolic ovarian syndrome in 2026) |
| Where it's used | South Asian healthcare systems, patient education, everyday conversation | Canadian, international, and most Western clinical guidelines |
| What it emphasizes | The ovarian-appearance finding on ultrasound | The full hormonal, ovulatory, and metabolic syndrome |
| Formal diagnostic criteria | No single internationally standardized threshold | Rotterdam criteria — two of three features, after other causes are excluded |
| Canadian diagnostic standing | Not a recognized diagnostic category | The recognized diagnosis, charted as PCOS or PMOS |
| Long-term risk framing | Typically not addressed by the term itself | Includes insulin resistance, type 2 diabetes, and cardiovascular risk |
This isn't two diseases competing for the same patient. It's one condition described with different precision depending on where and when the term was coined. If a clinician somewhere else told you "PCOD," they were very likely describing the same underlying picture a Canadian clinician would chart as PCOS or PMOS, just through an older, narrower lens.
PCOS vs PCOD in Canadian clinical practice
Ask a Canadian family physician, OB-GYN, or endocrinologist which term they use, and the answer is consistent: PCOS, transitioning to PMOS. The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS, the document Canadian clinicians anchor to, treats the Rotterdam criteria as the sole diagnostic standard: two of three features (androgen excess, ovulatory dysfunction, polycystic ovarian morphology) after other causes are ruled out. PCOD doesn't appear anywhere in that framework, and it isn't a recognized diagnostic label under SOGC guidance either.
That doesn't make PCOD a wrong word. It's a term with a different origin, used by a different health system for a different purpose: informal shorthand or a regional clinical habit more than a distinct diagnostic tier. A 2025 systematic review of interventions for PCOS in Indian women, published in Pharmaceuticals and indexed on PMC, notes that clinicians there commonly use PCOD and PCOS as variant terms for the same condition, with PCOS prevalence estimated at roughly 10% under Rotterdam criteria. The overlap between the two terms is real. The precision behind them isn't equal.
For Canadian purposes, the practical upshot is simple: your chart, your lab requisition, and your specialist referral will say PCOS or PMOS. The treatment approach doesn't change based on which term got you into the room. See PCOS treatment in Canada for the full framework, which applies identically no matter what your prior diagnosis history says.
See if Cloudcure is right for you
If your records from another country say PCOD
If you immigrated to Canada, or you're comparing notes with family overseas, and your existing records say PCOD, here's what actually happens in a Canadian workup, because the honest answer is: probably not much extra, but it depends on what's already in the file.
If your prior workup included bloodwork and a symptom history, not just an ultrasound, a Canadian physician can often build directly on it. Androgen levels, cycle history, and ultrasound findings map onto the Rotterdam criteria regardless of which country or which term generated them. Your clinician will likely order updated labs, since the Canadian panel and timing differ slightly from what you may have had before, but that isn't the same as starting the diagnostic process from zero.
If your prior diagnosis was ultrasound-only, a common pattern where PCOD was used loosely for the imaging finding alone, expect a more complete workup. Canadian practice requires assessing all three Rotterdam criteria, not the ovarian appearance in isolation, so your physician will likely ask about cycle regularity and screen for clinical or biochemical androgen excess before confirming PCOS or PMOS formally.
Either way, you're not required to be "re-diagnosed from scratch," and a PCOD label on an old record isn't something to be defensive about. It reflects a real finding, described through a different regional lens. For the specifics of how PCOS is actually tested and confirmed in Canada, including which bloodwork and imaging get ordered and why, see our Canadian guide to PCOS.
SOPK: the French-Canadian term
One more term worth clarifying, because it sits alongside this comparison rather than inside it. SOPK (syndrome des ovaires polykystiques) is the standard French-Canadian clinical term for PCOS, used across Quebec and other francophone communities. If you're navigating care in French, or comparing notes with a médecin de famille or gynécologue who uses SOPK, that's simply the French equivalent of PCOS/PMOS: the same Rotterdam criteria, the same treatment framework. SOPK has no relationship to PCOD. The two terms come from entirely separate linguistic and regional traditions that happen to describe the same underlying syndrome.
How Cloudcure approaches PCOS care
Whatever term shows up on your existing records, PCOD, PCOS, PMOS, or SOPK, Cloudcure's PCOS care program starts from the same place: a proper Canadian workup, not an assumption based on old paperwork.
A baseline metabolic workup includes HbA1c, fasting insulin, a lipid panel, and a free-androgen-index calculation where appropriate, so your actual hormonal and metabolic picture gets measured rather than inferred from a prior diagnosis made under a different standard.
A 12-month structured arc runs with monthly clinician follow-up and lab reviews at months 3, 6, and 12, anchored to the same 2023 international guideline framework regardless of what your intake paperwork says.
Coordination with your family physician, OB-GYN, or endocrinologist means we don't replace them, and we don't need you to have already sorted out which acronym applies before booking. Working that out is part of what the intake workup is for.
Membership is $99 per month and is HSA- and HCSA-eligible across major Canadian benefits providers. Eligibility takes about five minutes, and bringing a prior PCOD diagnosis, or any other prior record, to that conversation only helps your clinician get oriented faster.
Start your eligibility check
The bottom line
Three things worth holding onto:
- PCOD and PCOS are not strict synonyms, even though they're often used that way. PCOD is an older, regional term emphasizing the ovarian-appearance finding; PCOS is the recognized syndrome, now renamed PMOS, that Canadian clinicians actually diagnose and chart.
- Canada uses the Rotterdam criteria, full stop. PCOD doesn't appear in Canadian or international diagnostic frameworks, but a PCOD label on an old record almost always reflects the same underlying condition described through a narrower lens.
- Treatment doesn't change based on which acronym got you here. Lifestyle first, behavioural support, and prescription options where clinically appropriate: the same framework applies whether your chart says PCOD, PCOS, PMOS, or SOPK.
If you have a diagnosis from elsewhere and want a Canadian workup that takes it seriously instead of starting over, take Cloudcure's three-minute eligibility check. For the insulin resistance driving most of the long-term risk behind both the PCOD and PCOS pictures, see our Canadian guide to insulin resistance.